Impact of scFv Sequence and Position on the Functionality of Bispecific Antibodies against Omicron Variants EG.5 and BA.2.86
Ma, Y., Liu, Q., Rehati, P., Zhang, Z., Zhao, J., Wu, F., Sun, L., Huang, J.To be published.
Experimental Data Snapshot
wwPDB Validation 3D Report Full Report
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Spike protein S1 | 222 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 18  Gene Names: S, 2 | ![]() | |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P0DTC2 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| GW01 scFv | 251 | Homo sapiens | Mutation(s): 0  | ![]() | |
Entity ID: 3 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| 7F3 scFv | 260 | Homo sapiens | Mutation(s): 0  | ![]() | |
| Task | Software Package | Version |
|---|---|---|
| MODEL REFINEMENT | PHENIX | |
| Funding Organization | Location | Grant Number |
|---|---|---|
| Not funded | -- |